• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越应激自我:健康细胞上NKG2D配体表达的证据。

Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.

作者信息

Eagle Robert A, Jafferji Insiya, Barrow Alexander D

机构信息

University of Cambridge, Department of Pathology, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Cambridge, CB2 0XY, UK.

出版信息

Curr Immunol Rev. 2009 Feb;5(1):22-34. doi: 10.2174/157339509787314369.

DOI:10.2174/157339509787314369
PMID:19626129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2713595/
Abstract

The activity of cytotoxic lymphocytes is regulated by the opposing function of stimulatory and inhibitory cell surface receptors. According to the now classical model of Natural Killer (NK) cell activity, the ligands for inhibitory receptors are constitutively expressed on healthy cells but can be lost on infection and on malignant cells. Loss of inhibitory checks will then allow activating signals to predominate, forming the basis of 'missing self recognition'. Natural Killer Group 2D (NKG2D) is an important member of the cohort of activating receptors expressed on Natural Killer (NK) cells and subsets of T cells. Ligands for the NKG2D receptor comprise a diverse array of self-proteins structurally related to MHC class I molecules. Expression of NKG2D ligands can be induced in cells during infection with pathogens, tumourigenesis, and by stimuli such as DNA damage, oxidative stress, and heat shock. Consequently NKG2D has been widely described as participating in 'stressed self' or 'damaged self' recognition. However, a body of evidence has recently emerged to suggest that this intuitive model of NKG2D function may be an oversimplification. NKG2D ligand expression has now widely been reported on cells that could not be described as stressed or damaged. For example activated T cells can express NKG2D ligands, and constitutive expression of NKG2D ligands has been reported on normal myelomonocytic cells, dendritic cells, and epithelial cells of the gut mucosa. In this article we will review the literature suggesting that NKG2D may function to recognise non-stressed cells and discuss the role NKG2D ligands could be playing in apparently healthy cells.

摘要

细胞毒性淋巴细胞的活性受刺激性和抑制性细胞表面受体的相反功能调节。根据目前经典的自然杀伤(NK)细胞活性模型,抑制性受体的配体在健康细胞上组成性表达,但在感染和恶性细胞上可能会丢失。抑制性检查的丧失将使激活信号占主导地位,形成“缺失自我识别”的基础。自然杀伤细胞2D(NKG2D)是在自然杀伤(NK)细胞和T细胞亚群上表达的激活受体群体的重要成员。NKG2D受体的配体包括一系列与MHC I类分子结构相关的自身蛋白。NKG2D配体的表达可在病原体感染、肿瘤发生期间以及受到DNA损伤、氧化应激和热休克等刺激时在细胞中诱导产生。因此,NKG2D被广泛描述为参与“应激自我”或“受损自我”识别。然而,最近出现了大量证据表明,这种直观的NKG2D功能模型可能过于简单化。现在广泛报道NKG2D配体在不能被描述为应激或受损的细胞上表达。例如,活化的T细胞可以表达NKG2D配体,并且在正常骨髓单核细胞、树突状细胞和肠道黏膜上皮细胞上已报道有NKG2D配体的组成性表达。在本文中,我们将回顾表明NKG2D可能具有识别非应激细胞功能的文献,并讨论NKG2D配体在明显健康的细胞中可能发挥的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/d634472459f6/ukmss-27306-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/6e1c0edec668/ukmss-27306-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/d773ad7f4df9/ukmss-27306-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/3f20a818513c/ukmss-27306-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/d634472459f6/ukmss-27306-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/6e1c0edec668/ukmss-27306-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/d773ad7f4df9/ukmss-27306-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/3f20a818513c/ukmss-27306-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f198/2713595/d634472459f6/ukmss-27306-f0004.jpg

相似文献

1
Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.超越应激自我:健康细胞上NKG2D配体表达的证据。
Curr Immunol Rev. 2009 Feb;5(1):22-34. doi: 10.2174/157339509787314369.
2
More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.不仅仅是装饰:免疫细胞表达自然杀伤细胞组 2 成员 D 配体的作用。
Front Immunol. 2018 Feb 12;9:231. doi: 10.3389/fimmu.2018.00231. eCollection 2018.
3
NKG2D and Related Immunoreceptors.自然杀伤细胞2D及相关免疫受体
Adv Protein Chem. 2004;68:281-312. doi: 10.1016/S0065-3233(04)68008-9.
4
Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?NKG2D与其抑制性对应物的失衡:肿瘤如何逃避先天免疫?
Int Immunopharmacol. 2005 Jul;5(7-8):1099-111. doi: 10.1016/j.intimp.2005.03.003. Epub 2005 Apr 1.
5
Targeting NKG2D in tumor surveillance.靶向 NKG2D 进行肿瘤监视。
Expert Opin Ther Targets. 2012 Jun;16(6):587-99. doi: 10.1517/14728222.2012.681378. Epub 2012 Apr 25.
6
Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer.
Mol Immunol. 2002 May;38(14):1029-37. doi: 10.1016/s0161-5890(02)00032-9.
7
The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.平衡之举:抑制性Ly49调节NKG2D介导的自然杀伤细胞功能。
Semin Immunol. 2006 Jun;18(3):186-92. doi: 10.1016/j.smim.2006.04.002.
8
Regulation of ligands for the activating receptor NKG2D.激活型受体NKG2D的配体调控
Immunology. 2007 Aug;121(4):439-47. doi: 10.1111/j.1365-2567.2007.02652.x.
9
New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1.自然杀伤细胞2型成员D(NKG2D)及其配体调控的新见解:内质网应激与癌胚抗原相关细胞黏附分子1
Front Immunol. 2018 Jun 18;9:1324. doi: 10.3389/fimmu.2018.01324. eCollection 2018.
10
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.NKG2D/NKG2DL 轴在免疫细胞和髓系细胞相互作用中的作用及其在疾病中的意义。
Front Immunol. 2018 Apr 23;9:827. doi: 10.3389/fimmu.2018.00827. eCollection 2018.

引用本文的文献

1
NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity.自然杀伤细胞(NK细胞)上NKG2D配体的表达会诱导细胞因子信号传导的NKG2D介导的交叉耐受,并降低NK细胞的肿瘤免疫。
J Immunol. 2025 Jun 1;214(6):1410-1421. doi: 10.1093/jimmun/vkaf030.
2
CAR-T in cancer therapeutics and updates.嵌合抗原受体T细胞疗法在癌症治疗中的应用及进展
J Natl Cancer Cent. 2024 Jan 9;4(3):189-194. doi: 10.1016/j.jncc.2024.01.001. eCollection 2024 Sep.
3
Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review.

本文引用的文献

1
Pillars article: Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999. 286: 1957-1959.专栏文章:家族性噬血细胞性淋巴组织细胞增生症中的穿孔素基因缺陷。《科学》。1999年。第286卷:第1957 - 1959页。
J Immunol. 2015 Jun 1;194(11):5044-6.
2
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.人类微小RNA调控由NKG2D受体介导的应激诱导免疫反应。
Nat Immunol. 2008 Sep;9(9):1065-73. doi: 10.1038/ni.1642.
3
IL-21 augments natural killer effector functions in chronically HIV-infected individuals.
膀胱癌肿瘤微环境进展及其潜在分子机制:一项系统综述
Discov Oncol. 2024 Apr 11;15(1):111. doi: 10.1007/s12672-024-00902-8.
4
Bystander activated CD8 T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity.旁观者激活的CD8 T细胞在病毒感染期间通过不依赖抗原的细胞毒性介导神经病理学。
Nat Commun. 2024 Feb 5;15(1):896. doi: 10.1038/s41467-023-44667-0.
5
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells.双重靶向肿瘤代谢组和应激抗原会影响工程 T 细胞的转录组异质性和疗效。
Nat Immunol. 2024 Jan;25(1):88-101. doi: 10.1038/s41590-023-01665-0. Epub 2023 Nov 27.
6
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer.NKG2D/NKG2D配体系统在癌症中的作用与调控
Biology (Basel). 2023 Aug 2;12(8):1079. doi: 10.3390/biology12081079.
7
T cells with split CARs specific for NKG2D ligands and PD-L1 exhibit improved selectivity towards monocyte-derived cells while effective in eliminating acute myeloid leukaemia in vivo.特异性识别 NKG2D 配体和 PD-L1 的分裂嵌合抗原受体 T 细胞在体内有效消除急性髓系白血病的同时,对单核细胞衍生细胞具有更好的选择性。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10189-10201. doi: 10.1007/s00432-023-04865-1. Epub 2023 Jun 3.
8
Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer.2型糖尿病诱导的细胞衰老在结直肠癌中的促肿瘤作用
Front Oncol. 2022 Aug 18;12:975644. doi: 10.3389/fonc.2022.975644. eCollection 2022.
9
Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia.NKG2D 配体的上调会损害范可尼贫血症患者造血干细胞的功能。
J Clin Invest. 2022 Aug 1;132(15). doi: 10.1172/JCI142842.
10
Sepsis Encephalopathy Is Partly Mediated by miR370-3p-Induced Mitochondrial Injury but Attenuated by BAM15 in Cecal Ligation and Puncture Sepsis Male Mice.盲肠结扎穿刺术诱导的脓毒症雄性小鼠中,miR370-3p 诱导的线粒体损伤部分介导了脓毒症脑病,但 BAM15 可减轻其损伤。
Int J Mol Sci. 2022 May 13;23(10):5445. doi: 10.3390/ijms23105445.
白细胞介素-21增强慢性HIV感染者的自然杀伤细胞效应功能。
AIDS. 2008 Aug 20;22(13):1551-60. doi: 10.1097/QAD.0b013e3283089367.
4
Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48.母胎界面的自然杀伤细胞配体:UL-16结合蛋白、MHC I类链相关分子、HLA-F和CD48。
Hum Reprod. 2008 Nov;23(11):2535-48. doi: 10.1093/humrep/den223. Epub 2008 Jul 24.
5
The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response.小鼠胚胎干细胞和体外分化神经元细胞的致瘤性受受体免疫反应的控制。
PLoS One. 2008 Jul 9;3(7):e2622. doi: 10.1371/journal.pone.0002622.
6
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.巨噬细胞移动抑制因子通过下调NKG2D促进卵巢癌的免疫逃逸。
J Immunol. 2008 Jun 1;180(11):7338-48. doi: 10.4049/jimmunol.180.11.7338.
7
NKG2D-dependent effector function of bronchial epithelium-activated alloreactive T-cells.支气管上皮激活的同种异体反应性T细胞的NKG2D依赖性效应功能。
Eur Respir J. 2008 Sep;32(3):563-70. doi: 10.1183/09031936.00096407. Epub 2008 Apr 16.
8
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.NKG2D基因缺陷型小鼠在自发恶性肿瘤模型中的肿瘤监测功能存在缺陷。
Immunity. 2008 Apr;28(4):571-80. doi: 10.1016/j.immuni.2008.02.016.
9
Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity.人类黑色素瘤中NKG2D配体MHC I类链相关基因A的细胞内滞留赋予免疫特权并阻止自然杀伤细胞介导的细胞毒性。
J Immunol. 2008 Apr 1;180(7):4606-14. doi: 10.4049/jimmunol.180.7.4606.
10
Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors.蛋白酶体抑制剂对NKG2D受体配体表达的选择性诱导。
Cancer Res. 2008 Mar 1;68(5):1546-54. doi: 10.1158/0008-5472.CAN-07-2973.